Kevin M. Flanigan, MD

Nationwide Children's Hospital Medical Professional

Contact Information

Biography

Kevin M. Flanigan, MD, is the Robert F. and Edgar T. Wolfe Foundation Endowed Chair in Neuromuscular Research at Nationwide Children’s Hospital, and Professor of Pediatrics and Neurology at The Ohio State University College of Medicine. Certified by the American Board of Psychiatry and Neurology in both Neurology and Neuromuscular Medicine, Dr. Flanigan is director of the Center for Gene Therapy in The Research Institute at Nationwide Children's and a leading expert in neuromuscular disorders. He also leads the world-class Neuromuscular Disorders program at Nationwide Children's, which provides coordinated care with pediatric experts from more than a dozen specialties.

Dr. Flanigan earned his medical degree from Rush Medical College and completed his internship at the University of Michigan Health System before completing his Neurology residency and fellowship in Neuromuscular Disorders at the Johns Hopkins Hospital, and an additional post-doctoral laboratory fellowship in Human Molecular Biology and Genetics at the University of Utah.

His primary research interest is in the genetic and molecular characterization of inherited neuromuscular diseases, and the development of therapies directed toward these diseases. A major focus of his laboratory concerns genotype/phenotype correlation in the dystrophinopathies, with the intention of increasing our understanding of the pathogenesis in this disease and translating this understanding into improved therapies. An experienced clinical trialist, he has sponsored three investigator-initiated IND applications for first-in-human gene therapies for Duchenne muscular dystrophy and Sanfilippo syndrome. He is a member of the Executive Board of the World Muscle Society, and a past chair of TREAT-NMD, the international neuromuscular disease consortium.

Academic and Clinical Areas
Awards, Honors & Organizations
  • Listed, Best Doctors in America
  • Member, Executive Board of the World Muscle Society, 2001 - Present
  • Editorial Board Member, Neuromuscular Disorders
  • Founder, Nationally-Recognized Nationwide Children’s Hospital and The Ohio State University Annual Myology Course
  • Incoming Chair, TREAT-NMD: an International Network for the Neuromuscular Field
  • Founding Editor, PLoS Currents Muscular Dystrophy
Education

Date of Appointment at Nationwide Children’s Hospital: 01/29/2010

Board Certifications
  • Neurology
  • Neuromuscular Medicine
Fellowship University of Utah Medical School Date Completed: 06/30/1997
Fellowship Johns Hopkins Hospital Date Completed: 06/30/1995
Residency Johns Hopkins Hospital Date Completed: 06/30/1994
Internship University of Michigan Health System Date Completed: 07/30/1991
Medical School Rush Medical College Date Completed: 06/09/1990
Professional Experience

2009 - Present Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Principal Investigator

2007 - 2009 University of Utah School of Medicine, Department of Pathology, Adjunct Associate Professor

2007 - 2009 University of Utah School of Medicine, Department of Pediatrics, Adjunct Associate Professor

2005 - 2009 University of Utah, Department of Human Genetics, Adjunct Associate Professor

2005 - 2009 University of Utah School of Medicine, Department of Neurology, Associate Professor

2006 - 2007 INSERM Unit 582, Institut de Myologie, Hopital Pitie-Salpetriere (Paris, France), Visiting Researcher

2000 - 2007 University of Utah School of Medicine, Department of Pediatrics, Adjunct Assistant Professor

1998 - 2007 University of Utah School of Medicine, Department of Pathology, Adjunct Assistant Professor

2001 - 2005 University of Utah, Department of Human Genetics, Adjunct Assistant Professor

1999 - 2004 University of Utah School of Medicine, Department of Neurology, Assistant Professor

1997 - 1998 University of Utah School of Medicine, Department of Neurology, Research Assistant Professor

1996 - 1998 University of Utah School of Medicine, Department of Pathology, Limited Term Instructor

1995 - 1997 University of Utah School of Medicine, Department of Neurology, Limited Term Instructor

The Future of Gene Therapy
Video

Transforming Neuromuscular Disease | The Future of Gene Therapy

Dr. Flanigan is director of the Center for Gene Therapy and a leading expert in neuromuscular disorders. His team leads the field in delivering gene therapies that can treat the underlying cause of inherited neuromuscular disorders like muscular dystrophy. That's something that other drugs and medications currently cannot do.